| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | United States | 6 | |
| #3 | WIPO (World Intellectual Property Organization) | 6 | |
| #4 | China | 5 | |
| #5 | Australia | 4 | |
| #6 | Canada | 4 | |
| #7 | Brazil | 2 | |
| #8 | Republic of Korea | 2 | |
| #9 | New Zealand | 2 | |
| #10 | South Africa | 2 | |
| #11 | EAPO (Eurasian Patent Organization) | 1 | |
| #12 | Ecuador | 1 | |
| #13 | Israel | 1 | |
| #14 | Japan | 1 | |
| #15 | Morocco | 1 | |
| #16 | Montenegro | 1 | |
| #17 | Mexico | 1 | |
| #18 | Norway | 1 | |
| #19 | Serbia | 1 | |
| #20 | Tunisia | 1 | |
| #21 | Ukraine | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Syringes | |
| #4 | Implantable devices | |
| #5 | Peptides | |
| #6 | Microorganisms | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Meyer Thomas | 27 |
| #2 | Guitton Matthieu | 15 |
| #3 | Puel Jean-Luc | 14 |
| #4 | Pujol Remy | 14 |
| #5 | Ruel Jerome | 3 |
| #6 | Wang Jing | 3 |
| #7 | Ruettiger Lukas | 2 |
| #8 | Knipper Marlies | 2 |
| #9 | Thomas Meyer | 2 |
| #10 | Jean-Luc Puel | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2015200768A2 | Pharmacologic treatments of menière's disease | |
| CN106455579A | Methods and compositions for treating and preventing tinnitus | |
| CA2849085A1 | Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system | |
| AU2006341983A1 | Use of an NMDA receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity | |
| UA89858C2 | pharmaceutical compositions for treatment of inner ear disorders | |
| CN104840416A | Medicinal composition for treating internal-ear disease | |
| CA2620374A1 | Pharmaceutical compositions for the treatment of inner ear disorders | |
| KR20130103615A | Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity |